Related Experiment Videos
Myelography with metrizamide in the cervical region
1Section of Neuroradiology, Faculty of Medicine, University of Copenhagen, Glostrup, Denmark.
Acta Radiologica. Supplementum
|January 1, 1977
Summary
Cervical myelography using Amipaque via lateral cervical puncture showed fewer adverse reactions like nausea and vomiting compared to the lumbar approach. Both methods were safe, with no serious complications reported.
Area of Science:
- Radiology
- Neurology
- Medical Imaging
Background:
- Cervical myelography is a diagnostic imaging technique.
- Metrizamide (Amipaque) is a contrast agent used in myelography.
- Evaluating adverse reactions is crucial for patient safety.
Purpose of the Study:
- To compare adverse reactions between lateral cervical puncture and lumbar injection for cervical myelography using metrizamide.
- To assess the safety and efficacy of different approaches for cervical myelography.
Main Methods:
- Cervical myelography was performed in 72 patients via lateral cervical puncture (C1-C2).
- Cervical myelography was performed in 21 patients via lumbar injection.
- Adverse reactions, including nausea and vomiting, were recorded and compared between the two groups.
Main Results:
- A slight but significant difference in adverse reactions was observed between the two methods.
- Lumbar injection for cervical myelography resulted in a significantly higher incidence of nausea and vomiting compared to the lateral cervical puncture approach.
- No serious adverse reactions were reported for either the lumbar or cervical approach.
Conclusions:
- Lateral cervical puncture for metrizamide cervical myelography is associated with a lower incidence of adverse reactions compared to the lumbar approach.
- Both methods are considered safe for cervical myelography, with no severe complications noted.